Terms: = Pancreatic cancer AND STAT3, FLJ20882, 6774, ENSG00000168610, APRF, P40763, MGC16063 AND Prognosis
89 results:
1. IL-22 signaling promotes sorafenib resistance in hepatocellular carcinoma via stat3/CD155 signaling axis.
Chen J; Sun S; Li H; Cai X; Wan C
Front Immunol; 2024; 15():1373321. PubMed ID: 38596684
[TBL] [Abstract] [Full Text] [Related]
2. Fundamental insights and molecular interactions in pancreatic cancer: Pathways to therapeutic approaches.
Gu M; Liu Y; Xin P; Guo W; Zhao Z; Yang X; Ma R; Jiao T; Zheng W
Cancer Lett; 2024 Apr; 588():216738. PubMed ID: 38401887
[TBL] [Abstract] [Full Text] [Related]
3. Corosolic acid enhances oxidative stress-induced apoptosis and senescence in pancreatic cancer cells by inhibiting the JAK2/stat3 pathway.
Luo X; Ye Z; Xu C; Chen H; Dai S; Chen W; Bao G
Mol Biol Rep; 2024 Jan; 51(1):176. PubMed ID: 38252208
[TBL] [Abstract] [Full Text] [Related]
4. ALYREF-mediated RNA 5-Methylcytosine modification Promotes Hepatocellular Carcinoma Progression Via Stabilizing EGFR mRNA and pstat3 activation.
Nulali J; Zhang K; Long M; Wan Y; Liu Y; Zhang Q; Yang L; Hao J; Yang L; Song H
Int J Biol Sci; 2024; 20(1):331-346. PubMed ID: 38164181
[TBL] [Abstract] [Full Text] [Related]
5. IL20RB signaling enhances stemness and chemotherapy resistance in pancreatic cancer.
Li XH; Huang GZ; Xu ZL; Zhao CY; Dong XY; Cui BK; Lin XJ
J Transl Med; 2023 Dec; 21(1):911. PubMed ID: 38098005
[TBL] [Abstract] [Full Text] [Related]
6. Hsa_circ_0009092/miR-665/NLK signaling axis suppresses colorectal cancer progression via recruiting TAMs in the tumor microenvironment.
Song J; Liu Q; Han L; Song T; Huang S; Zhang X; He Q; Liang C; Zhu S; Xiong B
J Exp Clin Cancer Res; 2023 Nov; 42(1):319. PubMed ID: 38008713
[TBL] [Abstract] [Full Text] [Related]
7. LncTUG1 promotes hepatocellular carcinoma immune evasion via upregulating PD-L1 expression.
Wu R; Liu W; Yang Q; Zhang J; Hou P; Xiong J; Wu L; Li E
Sci Rep; 2023 Oct; 13(1):16998. PubMed ID: 37813900
[TBL] [Abstract] [Full Text] [Related]
8. Tex10 interacts with stat3 to regulate hepatocellular carcinoma growth and metastasis.
Xiang X; Kuang W; Yu C; Li Y; Su Q; Tian Y; Li J
Mol Carcinog; 2023 Dec; 62(12):1974-1989. PubMed ID: 37792308
[TBL] [Abstract] [Full Text] [Related]
9. stat3 inhibition enhances gemcitabine sensitivity in pancreatic cancer by suppressing EMT, immune escape and inducing oxidative stress damage.
Guo H; Hu Z; Yang X; Yuan Z; Gao Y; Chen J; Xie L; Chen C; Guo Y; Bai Y
Int Immunopharmacol; 2023 Oct; 123():110709. PubMed ID: 37515849
[TBL] [Abstract] [Full Text] [Related]
10. TMPOP2 Inhibition Suppresses pancreatic cancer Cell Migration and Development by Repressing The JNK/stat3 Pathway.
Liang J; Cao H; Wang G; Wei L; Dong L; Chen G; Li Q; Zhu D
Adv Biol (Weinh); 2023 Dec; 7(12):e2300113. PubMed ID: 37469237
[TBL] [Abstract] [Full Text] [Related]
11. Molecular profile of metastasis, cell plasticity and EMT in pancreatic cancer: a pre-clinical connection to aggressiveness and drug resistance.
Guo Z; Ashrafizadeh M; Zhang W; Zou R; Sethi G; Zhang X
Cancer Metastasis Rev; 2024 Mar; 43(1):29-53. PubMed ID: 37453022
[TBL] [Abstract] [Full Text] [Related]
12. BICC1 drives pancreatic cancer progression by inducing VEGF-independent angiogenesis.
Huang C; Li H; Xu Y; Xu C; Sun H; Li Z; Ge Y; Wang H; Zhao T; Gao S; Wang X; Yang S; Sun P; Liu Z; Liu J; Chang A; Hao J
Signal Transduct Target Ther; 2023 Jul; 8(1):271. PubMed ID: 37443111
[TBL] [Abstract] [Full Text] [Related]
13. Adipocytes promote pancreatic cancer migration and invasion through fatty acid metabolic reprogramming.
Cai Z; Li Y; Ma M; Wang L; Wang H; Liu M; Jiang C
Oncol Rep; 2023 Jul; 50(1):. PubMed ID: 37264956
[TBL] [Abstract] [Full Text] [Related]
14. Systemic Alterations in Type-2 Conventional Dendritic Cells Lead to Impaired Tumor Immunity in pancreatic cancer.
James CA; Baer JM; Zou C; Panni UY; Knolhoff BL; Hogg GD; Kingston NL; Kang LI; Lander VE; Luo J; Tao Y; Watson MA; Aft R; Fields RC; Hawkins WG; DeNardo DG
Cancer Immunol Res; 2023 Aug; 11(8):1055-1067. PubMed ID: 37229629
[TBL] [Abstract] [Full Text] [Related]
15. LncRNA HClnc1 facilitates hepatocellular carcinoma progression by regulating PKM2 signaling and indicates poor survival outcome after hepatectomy.
Zhu Q; Lei Z; Xu C; Zhang Z; Yu Z; Cheng Z; Xiao P; Li S; Yu W; Zhou J
Cancer Med; 2023 Jul; 12(13):14526-14544. PubMed ID: 37212467
[TBL] [Abstract] [Full Text] [Related]
16. Protein tyrosine phosphatase nonreceptor type 2 exerts antimetastatic functions in pancreatic ductal adenocarcinoma.
Zhang S; Wang H; Mao P; Sun Q; Su H; Zhang Y; Shen S; Xu G; Wang L; Zou X; Zhan Q; Lv Y
Mol Carcinog; 2023 Aug; 62(8):1176-1190. PubMed ID: 37204217
[TBL] [Abstract] [Full Text] [Related]
17. A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinoma.
Chen Y; Lin X; Zou X; Qian Y; Liu Y; Wang R; Wang X; Yu X; Liu C; Cheng H
BMC Gastroenterol; 2023 Apr; 23(1):113. PubMed ID: 37024802
[TBL] [Abstract] [Full Text] [Related]
18. stat3 signaling in pancreatic ductal adenocarcinoma: a candidate therapeutic target.
Al-Hetty HRAK; Abdulameer SJ; Alkubaisy SA; Zaid SA; Jalil AT; Jasim IK
Pathol Res Pract; 2023 May; 245():154425. PubMed ID: 37019018
[TBL] [Abstract] [Full Text] [Related]
19. MARCO is a potential prognostic and immunotherapy biomarker.
Dong Q; Zhang S; Zhang H; Sun J; Lu J; Wang G; Wang X
Int Immunopharmacol; 2023 Mar; 116():109783. PubMed ID: 36773567
[TBL] [Abstract] [Full Text] [Related]
20. HOXB7 induces stat3-mediated transformation and lung metastasis in immortalized mammary gland NMuMG cells.
Azuma K; Sakamoto M; Katayama S; Matsui A; Nakamichi K; Goshima N; Watanabe S; Nakayama J; Semba K
Genes Cells; 2023 Apr; 28(4):277-287. PubMed ID: 36659836
[TBL] [Abstract] [Full Text] [Related]
[Next]
